Under construction – not a live service
Sign in
Taking people in United StatesPhase 2

Nurse case management to help formerly incarcerated Black men manage type 2 diabetes

Tests a nurse case manager for Black men with type 2 diabetes after prison release.

Plain-language title generated from the registry record
Registry title: MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly Incarcerated Black Men

Key facts

Where
Milwaukee, United StatesSee the site
Phase
Phase 2

Where in United States

  • Center for Advancing Population Science, Medical College of WisconsinMilwaukee, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Medical College of Wisconsin
Trial code
NCT06031428
Record updated
6 October 2026
Original description
The study is a randomized control trial involving 100 participants (formerly incarcerated Black men with poorly controlled diabetes) to examine the effect of a tailored nurse case manager on glycemic control and other clinical outcomes, self-care behaviors, and quality of life at 6 months post-randomization.Read full original descriptionShow less

MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly Incarcerated Black Men

The study is a randomized control trial involving 100 participants (formerly incarcerated Black men with poorly controlled diabetes) to examine the effect of a tailored nurse case manager on glycemic control and other clinical outcomes, self-care behaviors, and quality of life at 6 months post-randomization.

Inclusion: age ≥18 years; identify as Black or African American; identify as male; formerly incarcerated in a state or federal prison system or county jail; clinical diagnosis of type 2 diabetes with HbA1c ≥8% at the screening visit; able to communicate in English.

Exclusion: mental confusion on screening interview suggesting significant dementia; current participation in other diabetes clinical trials; active psychosis or acute mental disorder; life expectancy \<12 months; awaiting arraignment, trial, sentencing in the criminal legal system; on active surveillance by the criminal legal system, meaning on house arrest or subject to electronic monitoring.

ClinicalTrials.gov NCT06031428